Bioequivalence tests to be stimulated

The Korea Food and Drug Administration said that in its business briefing to the minister of Health and Welfare on March 19, bioequivalence tests need to be further activated via withdrawal of ex post facto reporting to doctors after substitute drug dispensing and of such dispensing prior notice to patients on the part of a pharmacist, adding that the policy of the ministry to raise the reimbur...